vs
NACCO INDUSTRIES INC（NC）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是NACCO INDUSTRIES INC的1.0倍（$69.8M vs $66.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -5.8%，领先389.8%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -5.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 11.9%）
纳科工业是一家总部位于美国俄亥俄州克利夫兰的上市控股公司，核心业务聚焦采矿与自然资源领域，旗下划分煤炭开采、北美采矿、矿产管理三大业务板块。其中煤炭开采板块采用服务型商业模式，依据长期合约为发电企业及活性炭生产商运营露天煤矿。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
NC vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.0倍
$66.8M
营收增速更快
RIGL
高出26.4%
-5.2%
净利率更高
RIGL
高出389.8%
-5.8%
两年增速更快
RIGL
近两年复合增速
11.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $66.8M | $69.8M |
| 净利润 | $-3.8M | $268.1M |
| 毛利率 | 18.0% | 91.5% |
| 营业利润率 | 11.3% | 33.2% |
| 净利率 | -5.8% | 384.0% |
| 营收同比 | -5.2% | 21.2% |
| 净利润同比 | -150.8% | 1769.2% |
| 每股收益（稀释后） | $-0.53 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NCRIGL
| Q4 25 | $66.8M | $69.8M | ||
| Q3 25 | $76.6M | $69.5M | ||
| Q2 25 | $68.2M | $101.7M | ||
| Q1 25 | $65.6M | $53.3M | ||
| Q4 24 | $70.4M | $57.6M | ||
| Q3 24 | $61.7M | $55.3M | ||
| Q2 24 | $52.3M | $36.8M | ||
| Q1 24 | $53.3M | $29.5M |
净利润NCRIGL
| Q4 25 | $-3.8M | $268.1M | ||
| Q3 25 | $13.3M | $27.9M | ||
| Q2 25 | $3.3M | $59.6M | ||
| Q1 25 | $4.9M | $11.4M | ||
| Q4 24 | $7.6M | $14.3M | ||
| Q3 24 | $15.6M | $12.4M | ||
| Q2 24 | $6.0M | $-1.0M | ||
| Q1 24 | $4.6M | $-8.2M |
毛利率NCRIGL
| Q4 25 | 18.0% | 91.5% | ||
| Q3 25 | 13.0% | 93.2% | ||
| Q2 25 | 10.0% | 95.6% | ||
| Q1 25 | 14.7% | 91.7% | ||
| Q4 24 | 12.0% | 89.9% | ||
| Q3 24 | 11.7% | 85.5% | ||
| Q2 24 | 13.4% | 92.4% | ||
| Q1 24 | 13.2% | 93.1% |
营业利润率NCRIGL
| Q4 25 | 11.3% | 33.2% | ||
| Q3 25 | 8.8% | 40.9% | ||
| Q2 25 | -0.1% | 60.1% | ||
| Q1 25 | 11.7% | 23.9% | ||
| Q4 24 | 5.5% | 28.9% | ||
| Q3 24 | 31.9% | 25.4% | ||
| Q2 24 | 14.1% | 1.2% | ||
| Q1 24 | 8.9% | -23.6% |
净利率NCRIGL
| Q4 25 | -5.8% | 384.0% | ||
| Q3 25 | 17.3% | 40.2% | ||
| Q2 25 | 4.8% | 58.6% | ||
| Q1 25 | 7.5% | 21.5% | ||
| Q4 24 | 10.7% | 24.9% | ||
| Q3 24 | 25.4% | 22.5% | ||
| Q2 24 | 11.4% | -2.8% | ||
| Q1 24 | 8.6% | -27.9% |
每股收益（稀释后）NCRIGL
| Q4 25 | $-0.53 | $14.11 | ||
| Q3 25 | $1.78 | $1.46 | ||
| Q2 25 | $0.44 | $3.28 | ||
| Q1 25 | $0.66 | $0.63 | ||
| Q4 24 | $0.99 | $0.82 | ||
| Q3 24 | $2.14 | $0.70 | ||
| Q2 24 | $0.81 | $-0.06 | ||
| Q1 24 | $0.61 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $49.7M | $155.0M |
| 总债务越低越好 | $100.8M | $52.5M |
| 股东权益账面价值 | $429.2M | $391.5M |
| 总资产 | $661.2M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.23× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NCRIGL
| Q4 25 | $49.7M | $155.0M | ||
| Q3 25 | $52.7M | $137.1M | ||
| Q2 25 | $49.4M | $108.4M | ||
| Q1 25 | $61.9M | $77.1M | ||
| Q4 24 | $72.8M | $77.3M | ||
| Q3 24 | $63.1M | $61.1M | ||
| Q2 24 | $62.4M | $49.1M | ||
| Q1 24 | $61.8M | $49.5M |
总债务NCRIGL
| Q4 25 | $100.8M | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | $99.4M | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | $29.0M | $60.0M | ||
| Q1 24 | $28.4M | $60.0M |
股东权益NCRIGL
| Q4 25 | $429.2M | $391.5M | ||
| Q3 25 | $426.4M | $117.6M | ||
| Q2 25 | $413.1M | $81.9M | ||
| Q1 25 | $409.1M | $18.6M | ||
| Q4 24 | $404.9M | $3.3M | ||
| Q3 24 | $397.3M | $-14.6M | ||
| Q2 24 | $384.1M | $-29.9M | ||
| Q1 24 | $381.6M | $-31.7M |
总资产NCRIGL
| Q4 25 | $661.2M | $513.6M | ||
| Q3 25 | $637.6M | $242.5M | ||
| Q2 25 | $631.3M | $206.7M | ||
| Q1 25 | $634.2M | $176.0M | ||
| Q4 24 | $631.7M | $164.0M | ||
| Q3 24 | $597.4M | $139.4M | ||
| Q2 24 | $560.1M | $128.4M | ||
| Q1 24 | $538.0M | $126.5M |
负债/权益比NCRIGL
| Q4 25 | 0.23× | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | 0.25× | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.08× | — | ||
| Q1 24 | 0.07× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.4M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流NCRIGL
| Q4 25 | $11.4M | $22.0M | ||
| Q3 25 | $42.3M | $24.0M | ||
| Q2 25 | $-7.8M | $30.5M | ||
| Q1 25 | $5.0M | $-893.0K | ||
| Q4 24 | $25.2M | $14.5M | ||
| Q3 24 | $2.8M | $21.7M | ||
| Q2 24 | $4.1M | $302.0K | ||
| Q1 24 | $-9.8M | $-5.0M |
现金转化率NCRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 3.19× | 0.86× | ||
| Q2 25 | -2.39× | 0.51× | ||
| Q1 25 | 1.03× | -0.08× | ||
| Q4 24 | 3.33× | 1.01× | ||
| Q3 24 | 0.18× | 1.75× | ||
| Q2 24 | 0.68× | — | ||
| Q1 24 | -2.14× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NC
| Transferred Over Time | $42.7M | 64% |
| Transferred At Point In Time | $24.1M | 36% |
RIGL
暂无分部数据
